Status:
COMPLETED
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
Lead Sponsor:
Procter and Gamble
Conditions:
Healthy Subjects
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
Single usage, open label study in 16 adult healthy males. Eligible subjects will receive a single usage of the investigational device. Retention of the radiolabeled device will be monitored using gamm...
Eligibility Criteria
Inclusion
- Refrain from nasal, throat, or lung inhalants and exercise for 24 hour prior to the test
- Are able to tolerate the procedure and
- Be generally healthy
Exclusion
- Have history of allergy or hypersensitivity to the study ingredients
- Major diseases
- Taking medication regularly
- Radiation exposure recently
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00754091
Start Date
June 1 2008
End Date
June 1 2008
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter J Doll, PhD, RPh
Lexington, Kentucky, United States, 40503